Alfentanil: Simultaneous Testing Pilot

Novel Noninvasive Assessment of Cytochrome P4450 Activity: Simultaneous Testing Pilot

NCT01008059•Washington University School of Medicine

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Evaluate Two Paradigms for Simultaneous Assessment of Hepatic and Intestinal CYP3A

Interventions

Alfentanil

Locations

United States

Locations (1)

Washington University/Barnes Jewish Hospital

St Louis, Missouri, United States

Key Dates

Start Date

October 1, 2009

Primary Completion Date

September 1, 2016

Completion Date

September 1, 2016

Last Updated

May 17, 2019

Sponsors

Lead Sponsor

Washington University School of Medicine

Collaborators

National Institute of General Medical Sciences (NIGMS)

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 17, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions